GenowaySTU:JEH +5.88%62 FCF Margin % is -7.38% as of Dec. 2025. GuruFocus rates STU:JEH with a GF Score™ of 62/100 and a GF Value™ of €2.77 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 957 Biotechnology companies, Genoway ranks better than 52.98% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genoway's Free Cash Flow for the
six
months ended in Dec. 2025 was €-0.84 Mil. Genoway's Revenue for the
six
months ended in Dec. 2025 was €11.35 Mil. Therefore, Genoway's FCF Margin % for the quarter that ended in Dec. 2025 was -7.38%.
The historical rank and industry rank for Genoway's FCF Margin % or its related term are showing as below:
STU:JEH'
s FCF Margin % Range Over the Past 10 Years
Min: -58.95 Med: 2.57 Max: 13.57
Current: -58.94
During the past 13 years, the highest FCF Margin % of Genoway was 13.57%. The lowest was -58.95%. And the median was 2.57%.
STU:JEH's FCF Margin % is ranked better than 52.98% of 957
companies
in the Biotechnology industry
Industry Median: -84.65
vs STU:JEH: -58.94
Genoway FCF Margin % Related Terms
Genoway FCF Margin % Historical Data
* Premium members only.
The historical data trend for Genoway's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:JEH vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Genoway's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genoway FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genoway's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Genoway's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genoway (STU:JEH) has a FCF Margin % of -7.38% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Genoway and its competitors. According to the industry distribution chart, Genoway ranks #450 out of 957 companies in the Biotechnology industry, placing it in the top 47%.
Is Genoway's FCF Margin % too high?
Genoway's current FCF Margin % is -7.38%. Based on the distribution chart, Genoway ranks #450 out of 957 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Genoway has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genoway's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genoway ranks #450 out of 957 companies for FCF Margin %. This puts Genoway in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Genoway and its competitors. Genoway's current FCF Margin % is -7.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genoway stock overvalued right now?
Based on GuruFocus' analysis, Genoway (STU:JEH) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.77, compared to a current price of €2.34 — trading 15.5% below its estimated fair value. The current FCF Margin % is -7.38%. Genoway's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Genoway (STU:JEH), the current FCF Margin % is -7.38% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genoway (STU:JEH) Overvalued in 2026?
Based on GuruFocus' analysis, Genoway stock appears to be undervalued.
The current stock price of €2.34 is trading 15.5% below its estimated GF Value™ of €2.77.
GuruFocus considers Genoway to be Modestly Undervalued.
Key valuation signals for STU:JEH:
FCF Margin %: -7.38%
GF Value™: €2.77 vs. price of €2.34 (15.5% below fair value)
No single metric tells the full story. See the STU:JEH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmaceutical industries and research industries.
62GF Score
Get the complete analysis for STU:JEH
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:JEH has been successfully added to your 
